The Effects of Vasointestinal Peptide and Naringenin on Rotenone-Induced Experimental Model of Parkinson's Disease

The Effects of Vasointestinal Peptide and Naringenin on Rotenone-Induced Experimental Model of Parkinson's Disease

Aim: The aim of this study was to evaluate the intraperitoneal administration of naringenin and vasointestinal peptide (VIP), which are shown effective in various scientific studies, in terms of anti-Parkinsonian activity in rats. Material and Methods: Forty-eight Wistar albino female rats were divi...

Full description

Bibliographic Details
Main Authors:	Recep Özmerdivenli, Ferhat Şirinyıldız, Ayşe Nur Yıldırım
Format:	Article
Language:	English
Published:	Duzce University 2023-08-01
Series:	Düzce Tıp Fakültesi Dergisi
Subjects:	parkinson hastalığı rotenon sıçanlar vazointestinal peptit parkinson rats rotenone vasointestinal peptide
Online Access:	https://dergipark.org.tr/en/download/article-file/3160377

Similar Items

Effect of Dl-3-n-Butylphthalide on olfaction in rotenone-induced Parkinson’s rats
by: Jiawei Wang, et al.
Published: (2024-04-01)

Neuroprotective effects of Danshensu on rotenone-induced Parkinson’s disease models in vitro and in vivo
by: Tian Wang, et al.
Published: (2020-01-01)

Rotenone: from modelling to implication in Parkinson’s disease
by: Khaled Radad, et al.
Published: (2019-11-01)

Rosinidin inhibits NF-κB/ Nrf2/caspase-3 expression and restores neurotransmitter levels in rotenone-activated Parkinson's disease
by: Amira M. Alghamdi, et al.
Published: (2023-06-01)

Europinidin Inhibits Rotenone-Activated Parkinson’s Disease in Rodents by Decreasing Lipid Peroxidation and Inflammatory Cytokines Pathways
by: Ali Altharawi, et al.
Published: (2022-10-01)

Neuroprotective effects of sinapic acid involve the iron regulatory role on the rotenone-induced Parkinson’s disease model
by: Bahattin Avcı, et al.
Published: (2023-01-01)

Neuroprotective effects of nanogold-based Ayurveda medicine Suvarna Bhasma against rotenone-induced Parkinson's-like model
by: Snehasis Biswas, et al.
Published: (2024-01-01)

Pyrrolidine dithiocarbamate ameliorates rotenone-induced Parkinson’s disease in rats
by: Noha F. Abdelkader, et al.
Published: (2017-06-01)

Autophagy Disruptions Associated With Altered Optineurin Expression in Extranigral Regions in a Rotenone Model of Parkinson's Disease
by: John P. Wise, et al.
Published: (2018-05-01)

Adulthood Exposure to Lipopolysaccharide Exacerbates the Neurotoxic and Inflammatory Effects of Rotenone in the Substantia Nigra
by: Chun Huang, et al.
Published: (2017-05-01)

Non-Reproducibility of Oral Rotenone as a Model for Parkinson’s Disease in Mice
by: Ellen Niederberger, et al.
Published: (2022-10-01)

Rotenone-induced PINK1/Parkin-mediated mitophagy: establishing a silkworm model for Parkinson’s disease potential
by: Hantao Zhang, et al.
Published: (2024-04-01)

Neuroprotective effect of methanolic extract of Sargassum wightii on rotenone-induced parkinsonism-like symptoms in Wistar albino rats
by: Sradhasini Rout, et al.
Published: (2021-10-01)

Investigating the Effects of Whey-supplemented Swimming Training on Improving Motor Dysfunction and Neuronal Apoptosis in a Rotenone-induced Parkinson\'s Disease Model
by: Bita Tajik, et al.
Published: (2023-12-01)

Curcumin neuroprotective effects in Parkinson disease during pregnancy
by: Faramarz Khosravi, et al.
Published: (2023-09-01)

TRH Analog, Taltirelin Protects Dopaminergic Neurons From Neurotoxicity of MPTP and Rotenone
by: Cong Zheng, et al.
Published: (2018-12-01)

Protective Effects of Polyphenol-Rich Extracts against Neurotoxicity Elicited by Paraquat or Rotenone in Cellular Models of Parkinson’s Disease
by: Mitali A. Tambe, et al.
Published: (2023-07-01)

Olfactory impairment is related to REM sleep deprivation in rotenone model of Parkinson's disease
by: Mariana F. Aurich, et al.

Reduced menthol sensitivity in a prodromal Parkinson’s disease model induced by intranasal rotenone treatment
by: Hajime Sato, et al.
Published: (2024-02-01)

Inhibition of Calpain Attenuates Degeneration of Substantia Nigra Neurons in the Rotenone Rat Model of Parkinson’s Disease
by: Vandana Zaman, et al.
Published: (2022-11-01)

Monoterpenoid Epoxidiol Ameliorates the Pathological Phenotypes of the Rotenone-Induced Parkinson’s Disease Model by Alleviating Mitochondrial Dysfunction
by: Yulia Aleksandrova, et al.
Published: (2023-03-01)

LAR Downregulation Protects the Astrocytic U251 and Cocultured SH-SY5Y Cells in a Rotenone-Induced Parkinson’s Disease Cell Model
by: Wei Zheng, et al.
Published: (2023-07-01)

Unravelling the Molecular Mechanisms of a Quercetin Nanocrystal for Treating Potential Parkinson’s Disease in a Rotenone Model: Supporting Evidence of Network Pharmacology and In Silico Data Analysis
by: Yeruva Sai Lakshmi, et al.
Published: (2023-10-01)

Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson’s disease rat model
by: Alshimaa Magdy, et al.
Published: (2022-09-01)

Spirulina Ameliorates Oxidative Damage and Inflammation in Rotenone-Induced Neurotoxicity in Male Mice
by: Marwa E.A. EL- Shamarka, et al.
Published: (2022-03-01)

Noscapine Prevents Rotenone-Induced Neurotoxicity: Involvement of Oxidative Stress, Neuroinflammation and Autophagy Pathways
by: Richard L. Jayaraj, et al.
Published: (2021-07-01)

Propionic Acid and Fasudil as Treatment against Rotenone Toxicity in an In Vitro Model of Parkinson’s Disease
by: Friederike Ostendorf, et al.
Published: (2020-05-01)

Curcumin modulation of L-dopa and rasagiline-induced neuroprotection in rotenone model of Parkinson’s disease
by: Marwa El-Shamarka, et al.
Published: (2023-02-01)

The Anxiolytic Drug Buspirone Prevents Rotenone-Induced Toxicity in a Mouse Model of Parkinson’s Disease
by: Sarah Thomas Broome, et al.
Published: (2022-02-01)

Adult health and transition stage-specific rotenone-mediated Drosophila model of Parkinson’s disease: Impact on late-onset neurodegenerative disease models
by: Mohamad Ayajuddin, et al.
Published: (2022-08-01)

Empagliflozin attenuates neurodegeneration through antioxidant, anti-inflammatory, and modulation of α-synuclein and Parkin levels in rotenone-induced Parkinson’s disease in rats
by: Sanaa Ahmed, et al.
Published: (2022-06-01)

Hepcidin Decreases Rotenone-Induced α-Synuclein Accumulation via Autophagy in SH-SY5Y Cells
by: Meiqi Li, et al.
Published: (2020-10-01)

Attenuated levels of phospholipids in the striatum of rats infused with rotenone causing hemiparkinsonism as detected by simple dye-lipid complex
by: Margabandhu Gopi, et al.
Published: (2017-12-01)

Cannabinoid type 2 (CB2) receptors activation protects against oxidative stress and neuroinflammation associated dopaminergic neurodegeneration in rotenone model of Parkinson’s disease
by: Hayate Javed, et al.
Published: (2016-08-01)

Absence of a synergic nigral proapoptotic effect triggered by REM sleep deprivation in the rotenone model of Parkinson´s disease
by: Luana C Kmita, et al.
Published: (2019-09-01)

القای مدل بیماری پارکینسون توسط روتنون در موش صحرایی
by: Arman Rahimmi, et al.
Published: (2014-10-01)

α-Bisabolol, a Dietary Bioactive Phytochemical Attenuates Dopaminergic Neurodegeneration through Modulation of Oxidative Stress, Neuroinflammation and Apoptosis in Rotenone-Induced Rat Model of Parkinson’s Disease
by: Hayate Javed, et al.
Published: (2020-10-01)

Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease
by: Briana R. De Miranda, et al.
Published: (2018-07-01)

The effect of low dose amphetamine in rotenone-induced toxicity in a mice model of Parkinson’s disease
by: Omar M.E. Abdel-Salam, et al.
Published: (2020-09-01)

The conserved DNMT1-dependent methylation regions in human cells are vulnerable to neurotoxicant rotenone exposure
by: Dana M. Freeman, et al.
Published: (2020-03-01)